These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27333746)

  • 21. A critical assessment of the current pharmacotherapy for the treatment of embolic strokes of undetermined source.
    Lattanzi S; Acampa M; Norata D; Broggi S; Caso V
    Expert Opin Pharmacother; 2022 Jun; 23(8):905-915. PubMed ID: 35470761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    Tomita H; Sasaki S; Hagii J; Metoki N
    J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke of undetermined cause: workup and secondary prevention.
    Weimar C
    Curr Opin Neurol; 2016 Feb; 29(1):4-8. PubMed ID: 26641813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.
    Kiyuna F; Sato N; Matsuo R; Kamouchi M; Hata J; Wakisaka Y; Kuroda J; Ago T; Kitazono T;
    JAMA Netw Open; 2018 Sep; 1(5):e182953. PubMed ID: 30646186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source.
    Kamel H; Navi BB; Parikh NS; Merkler AE; Okin PM; Devereux RB; Weinsaft JW; Kim J; Cheung JW; Kim LK; Casadei B; Iadecola C; Sabuncu MR; Gupta A; Díaz I
    Stroke; 2020 Sep; 51(9):e203-e210. PubMed ID: 32781943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Embolic Stroke of Undetermined Source in Latin America: A Review.
    Cantú-Brito C; Sampaio Silva G; Ameriso SF
    Neurologist; 2017 Sep; 22(5):171-181. PubMed ID: 28859022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Embolic stroke of undetermined source (ESUS) : How much monitoring is necessary?].
    Stegmann T; Wachter R; Schäbitz WR
    Herz; 2019 Jun; 44(4):289-295. PubMed ID: 31062047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke prevention in atrial fibrillation and other major cardiac sources of embolism.
    Freeman WD; Aguilar MI
    Neurol Clin; 2008 Nov; 26(4):1129-60, x-xi. PubMed ID: 19026905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source.
    Hawkes MA; Farez MF; Pertierra L; Gomez-Schneider MM; Pastor-Rueda JM; Ameriso SF
    Int J Stroke; 2018 Feb; 13(2):190-194. PubMed ID: 28756759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source.
    Ricci B; Chang AD; Hemendinger M; Dakay K; Cutting S; Burton T; Mac Grory B; Narwal P; Song C; Chu A; Mehanna E; McTaggart R; Jayaraman M; Furie K; Yaghi S
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1692-1696. PubMed ID: 29501269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Case Report of Embolic Stroke of Undetermined Source.
    Li J; Yang XZ; Wang YP; Chen XL; Zhang X
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e133-e137. PubMed ID: 28476509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A systematic review of the characteristics and prognosis of subjects who suffer an embolic stroke of undetermined source].
    Molina-Seguin J; Vena AB; Colas-Campas L; Benalbdelhak I; Purroy F
    Rev Neurol; 2018 May; 66(10):325-330. PubMed ID: 29749592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant submassive pulmonary embolism and paradoxical embolic stroke after a long flight: which is the optimal treatment?
    Pavesi PC; Pedone C; Crisci M; Piacentini A; Fulvi M; Di Pasquale G
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1070-3. PubMed ID: 18799974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source.
    Ohya Y; Osaki M; Fujimoto S; Jinnouchi J; Matsuki T; Mezuki S; Kumamoto M; Kanazawa M; Tagawa N; Ago T; Kitazono T; Arakawa S
    Cerebrovasc Dis Extra; 2019; 9(3):98-106. PubMed ID: 31542780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.
    Chatterjee S; Dubey S; Lahiri D; Ray BK
    Minerva Cardioangiol; 2019 Aug; 67(4):340-347. PubMed ID: 31220915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.